Affinage

AP2S1

AP-2 complex subunit sigma · UniProt P53680

Length
142 aa
Mass
17.0 kDa
Annotated
2026-04-28
19 papers in source corpus 7 papers cited in narrative 7 extracted findings

Mechanistic narrative

Synthesis pass · prose summary of the discoveries below

AP2S1 encodes the σ2 subunit of the heterotetrameric AP2 clathrin adaptor complex, functioning as an essential mediator of clathrin-mediated endocytosis and intracellular membrane trafficking. The Arg15 residue of AP2σ2 directly contacts dileucine-based sorting motifs on cargo proteins such as the calcium-sensing receptor (CaSR); missense mutations at Arg15 impair AP2σ2–CaSR interaction and reduce CaSR endocytosis, causing familial hypocalciuric hypercalcemia type 3 (FHH3) (PMID:23222959, PMID:33729479). Beyond canonical endocytosis, AP2S1 regulates amyloid precursor protein (APP) degradation by modulating late endosome–lysosome fusion in a VPS41-dependent manner (PMID:36412210). Homozygous loss of Ap2s1 in mice is embryonic lethal (E3.5–9.5), establishing it as indispensable for early development (PMID:29479578).

Mechanistic history

Synthesis pass · year-by-year structured walk · 6 steps
  1. 1996 Medium

    Identifying the gene encoding the small σ chain of the AP-2 clathrin adaptor complex resolved its chromosomal location and established AP2S1 as a core structural component of the plasma membrane clathrin adaptor.

    Evidence cDNA cloning and chromosomal mapping by in situ hybridization in human cells

    PMID:9040778

    Open questions at the time
    • No functional characterization of the σ2 subunit's contribution to AP-2 complex activity
    • No cargo-binding mechanism defined
  2. 1998 Low

    Discovery of an alternatively spliced AP2S1 transcript (AP17Δ) in leukocytes raised the possibility of cell-type-specific AP-2 regulation, though its functional significance remained undefined.

    Evidence RT-PCR and sequence analysis from leukocyte cDNA libraries

    PMID:9767099

    Open questions at the time
    • No functional characterization of the AP17Δ isoform
    • Expression restricted to a single cell lineage without replication
    • No protein-level confirmation of AP17Δ
  3. 2012 High

    Linking AP2S1 Arg15 mutations to FHH3 revealed the molecular basis of cargo recognition: Arg15 makes direct contacts with dileucine-based sorting motifs, and its mutation reduces CaSR endocytosis, dysregulating calcium homeostasis.

    Evidence Mutational analysis of FHH3 patient cohorts combined with CaSR endocytosis and intracellular signaling assays in CaSR-expressing cells; disruption of CaSR C-terminal dileucine motif confirmed the functional interaction

    PMID:23222959

    Open questions at the time
    • Structural details of the Arg15–dileucine interaction at atomic resolution not determined
    • Effects of Arg15 mutations on non-CaSR cargo unknown
    • Whether other AP2σ2 residues contribute to cargo sorting untested
  4. 2017 High

    Demonstrating embryonic lethality of homozygous Ap2s1 loss established that AP2σ2 is non-redundant and essential for early mammalian development, while heterozygous deletion is haplosufficient.

    Evidence ENU mutagenesis-derived Ap2s1 splice-site variant in mice; homozygous lethality E3.5–9.5; heterozygous biochemical and mineral metabolism phenotyping

    PMID:29479578

    Open questions at the time
    • Specific developmental process(es) requiring AP2σ2 not identified
    • Whether lethality reflects loss of endocytosis globally or a specific cargo pathway unknown
  5. 2021 High

    A CRISPR knock-in mouse model of p.Arg15Leu showed that this mutation disrupts AP2σ2 interactions with all three other AP2 subunits and with CaSR, demonstrating that Arg15 integrity is required for both complex assembly and cargo engagement; cinacalcet corrected calcium/PTH in vivo without restoring the impaired AP2σ2–CaSR interaction.

    Evidence CRISPR/Cas9 Arg15Leu knock-in mice; co-immunoprecipitation for AP2 subunit and CaSR interactions; in vivo cinacalcet treatment

    PMID:33729479

    Open questions at the time
    • How cinacalcet normalizes calcium independently of AP2σ2–CaSR binding is mechanistically unclear
    • Whether impaired complex assembly is a primary driver or secondary to misfolding not resolved
  6. 2022 Medium

    Revealing an endocytosis-independent role for AP2S1 in APP lysosomal degradation showed that AP2σ2 controls late endosome–lysosome fusion via a VPS41-dependent pathway, expanding its function beyond the plasma membrane.

    Evidence AP2S1 knockdown/overexpression in APP695-expressing cells; RAB9/LAMP1 co-localization; VPS41 epistasis; AAV-mediated AP2S1 shRNA in APP/PS1 mouse hippocampus with behavioral testing

    PMID:36412210

    Open questions at the time
    • Mechanism by which AP2σ2 influences VPS41-dependent late endosome–lysosome fusion not defined
    • Whether this non-canonical role extends to cargoes other than APP untested
    • Single-lab finding awaiting independent replication

Open questions

Synthesis pass · forward-looking unresolved questions
  • Key unresolved questions include the full spectrum of AP2σ2 cargo proteins beyond CaSR and APP, the structural basis of how disease-associated variants outside Arg15 disrupt AP2 complex integrity and interactome, and the specific developmental pathways responsible for homozygous lethality.
  • No systematic cargo profiling for AP2σ2
  • No high-resolution structure of AP2σ2 disease mutants in complex with cargo
  • Developmental mechanism of Ap2s1 null lethality uncharacterized

Mechanism profile

Synthesis pass · controlled-vocabulary classification · explore literature graph →
Molecular activity
GO:0060090 molecular adaptor activity 3 GO:0038024 cargo receptor activity 2
Localization
GO:0005886 plasma membrane 2 GO:0031410 cytoplasmic vesicle 2 GO:0005764 lysosome 1 GO:0005768 endosome 1
Pathway
R-HSA-5653656 Vesicle-mediated transport 3 R-HSA-382551 Transport of small molecules 2 R-HSA-9612973 Autophagy 1
Partners
AP2A1AP2B1AP2M1CASRVPS41
Complex memberships
AP-2 adaptor complex

Evidence

Reading pass · 7 per-paper findings extracted from the source corpus
Year Finding Method Journal Conf PMIDs
2012 AP2S1 encodes the σ subunit of the AP2 heterotetramer; missense mutations at Arg15 disrupt key contacts with dileucine-based motifs of CCV cargo proteins, reducing CaSR endocytosis and decreasing sensitivity of CaSR-expressing cells to extracellular calcium, establishing AP2S1 as a regulator of CaSR internalization and calcium homeostasis. Mutational analysis of FHH3 patients combined with cellular expression assays measuring CaSR endocytosis and intracellular signaling in CaSR-expressing cells; disruption of CaSR C-terminal dileucine motif confirmed functional interaction Nature genetics High 23222959
2021 The AP2S1 p.Arg15Leu mutation impairs protein-protein interactions between AP2σ2 and the other AP2 complex subunits (AP2α, AP2β2, AP2μ2), and also reduces direct interaction with CaSR, as demonstrated by co-immunoprecipitation; cinacalcet reduced plasma calcium and PTH in heterozygous knock-in mice but did not restore the diminished AP2σ2-CaSR interaction in vitro. CRISPR/Cas9 knock-in mice harboring p.Arg15Leu plus co-immunoprecipitation studies in cells; in vivo pharmacological rescue with cinacalcet Human molecular genetics High 33729479
2017 Homozygous loss of Ap2s1 in mice is lethal between embryonic days E3.5–9.5, indicating AP2σ has essential roles during early embryonic patterning and organogenesis; heterozygous Ap2s1+/del17 mice are haplosufficient with normal mineral metabolism, establishing that complete AP2σ loss is incompatible with development. ENU mutagenesis screen identifying a donor splice-site variant causing an in-frame 17-amino-acid deletion; heterozygous and homozygous mouse phenotyping including plasma biochemistry, PTH, and vitamin D measurements JBMR plus High 29479578
2022 AP2S1 regulates lysosomal degradation of amyloid precursor protein (APP) through a late endosome–lysosome fusion mechanism: knockdown of AP2S1 promotes translocation of APP from RAB9-positive late endosomes to LAMP1-positive lysosomes and enhances late endosome–lysosome fusion, reducing APP and Aβ levels independently of endocytosis; VPS41 silencing blocked this AP2S1-mediated regulation. AP2S1 knockdown/overexpression in APP695-expressing cells; morphological co-localization studies (RAB9, LAMP1 markers); VPS41 epistasis experiment; AAV-mediated AP2S1 shRNA delivery in APP/PS1 mouse hippocampus with cognitive testing Traffic (Copenhagen, Denmark) Medium 36412210
1996 Human AP2S1 (CLAPS2) encodes AP17, the small (σ) chain of the plasma membrane-associated clathrin adaptor complex AP-2, and maps to chromosome 19q13.2→q13.3. cDNA cloning and chromosomal assignment by in situ hybridization Cytogenetics and cell genetics Medium 9040778
1998 Alternative splicing of AP2S1 (CLAPS2) produces a second transcript encoding AP17Δ, a 142-aa variant lacking 38 amino acids of AP17, expressed in leukocytes and cultured leukemia cells. RT-PCR with isoform-specific primers from cDNA library; sequence analysis of both transcripts Gene Low 9767099
2024 AP2S1 variants at positions other than Arg15 (p.Arg10Trp, p.Arg10Gln, p.Lys18Glu, p.Lys18Asn, p.Arg61His) decrease cell viability, reduce clathrin-mediated endocytosis (transferrin uptake), and disrupt interactions with other AP2 complex subunits, thereby impairing AP2 complex formation; p.Arg10Trp additionally reduced interactions with 44 human proteins including intersectin-1, a component required for clathrin-coated pit formation and synaptic vesicle dynamics. Patient variant identification; cell viability assays; transferrin uptake CME assay; Co-IP/interaction studies with other AP2 subunits; mass spectrometry interactome for p.Arg10Trp bioRxivpreprint Medium bio_10.1101_2024.07.22.24310683

Source papers

Stage 0 corpus · 19 papers · ranked by NIH iCite citations
Year Title Journal Citations PMID
2012 Mutations in AP2S1 cause familial hypocalciuric hypercalcemia type 3. Nature genetics 188 23222959
1999 Localization of familial benign hypercalcemia, Oklahoma variant (FBHOk), to chromosome 19q13. American journal of human genetics 85 9915958
2014 Codon Arg15 mutations of the AP2S1 gene: common occurrence in familial hypocalciuric hypercalcemia cases negative for calcium-sensing receptor (CASR) mutations. The Journal of clinical endocrinology and metabolism 33 24731014
2015 Cinacalcet Treatment in an Adolescent With Concurrent 22q11.2 Deletion Syndrome and Familial Hypocalciuric Hypercalcemia Type 3 Caused by AP2S1 Mutation. The Journal of clinical endocrinology and metabolism 20 25993639
2017 Stepwise CaSR, AP2S1, and GNA11 sequencing in patients with suspected familial hypocalciuric hypercalcemia. Endocrine 17 28176280
2017 N-ethyl-N-nitrosourea-Induced Adaptor Protein 2 Sigma Subunit 1 (Ap2s1) Mutations Establish Ap2s1 Loss-of-Function Mice. JBMR plus 16 29479578
2016 AP2S1 and GNA11 mutations - not a common cause of familial hypocalciuric hypercalcemia. European journal of endocrinology 16 27913609
2013 Identification of AP2S1 mutation and effects of low calcium formula in an infant with hypercalcemia and hypercalciuria. The Journal of clinical endocrinology and metabolism 16 24081735
2021 Ap2s1 mutation causes hypercalcaemia in mice and impairs interaction between calcium-sensing receptor and adaptor protein-2. Human molecular genetics 15 33729479
2022 AP2S1 regulates APP degradation through late endosome-lysosome fusion in cells and APP/PS1 mice. Traffic (Copenhagen, Denmark) 13 36412210
2014 Mutational analysis of the adaptor protein 2 sigma subunit (AP2S1) gene: search for autosomal dominant hypocalcemia type 3 (ADH3). The Journal of clinical endocrinology and metabolism 12 24708097
2014 Analysis of AP2S1, a calcium-sensing receptor regulator, in familial and sporadic isolated hypoparathyroidism. The Journal of clinical endocrinology and metabolism 7 24423332
2020 Clinical and Biochemical Features in a Case of Familial Hypocalciuric Hypercalcemia Type 3 with AP2S1 Gene Mutation in Codon Arg15His. Case reports in pediatrics 6 32047691
2019 Cinacalcet sustainedly prevents pancreatitis in a child with a compound heterozygous SPINK1/AP2S1 mutation. Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] 6 31391146
2019 A Hong Kong Chinese kindred with familial hypocalciuric hypercalcaemia caused by AP2S1 mutation. F1000Research 4 31723423
1996 Human CLAPS2 encoding AP17, a small chain of the clathrin-associated protein complex: cDNA cloning and chromosomal assignment to 19q13.2-->q13.3. Cytogenetics and cell genetics 4 9040778
1998 A novel spliced transcript of human CLAPS2 encoding a protein alternative to clathrin adaptor protein AP17. Gene 2 9767099
2020 Familial hypocalciuric hypercalcaemia type 3: AP2S1 missense mutation. BMJ case reports 1 33168530
2025 Successful Treatment With Evocalcet Against Familial Hypocalciuric Hypercalcemia Type 3 (FHH3) Identified by AP2S1 Gene Mutation (p.Arg15Leu). Case reports in endocrinology 0 39949382